- Home
- OFS vs LUCD Comparison
OFS vs LUCD Comparison
Compare OFS & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFS
- LUCD
- Stock Information
- Founded
- OFS 2001
- LUCD 2018
- Country
- OFS United States
- LUCD United States
- Employees
- OFS N/A
- LUCD N/A
- Industry
- OFS Finance/Investors Services
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OFS Finance
- LUCD Health Care
- Exchange
- OFS Nasdaq
- LUCD Nasdaq
- Market Cap
- OFS 117.0M
- LUCD 108.0M
- IPO Year
- OFS 2012
- LUCD 2021
- Fundamental
- Price
- OFS $7.68
- LUCD $1.03
- Analyst Decision
- OFS
- LUCD Strong Buy
- Analyst Count
- OFS 0
- LUCD 5
- Target Price
- OFS N/A
- LUCD $3.70
- AVG Volume (30 Days)
- OFS 70.9K
- LUCD 1.5M
- Earning Date
- OFS 10-30-2025
- LUCD 11-12-2025
- Dividend Yield
- OFS 17.62%
- LUCD N/A
- EPS Growth
- OFS N/A
- LUCD N/A
- EPS
- OFS 0.76
- LUCD N/A
- Revenue
- OFS $43,337,000.00
- LUCD $4,360,000.00
- Revenue This Year
- OFS N/A
- LUCD $13.90
- Revenue Next Year
- OFS N/A
- LUCD $163.88
- P/E Ratio
- OFS $10.10
- LUCD N/A
- Revenue Growth
- OFS N/A
- LUCD 14.74
- 52 Week Low
- OFS $7.53
- LUCD $0.75
- 52 Week High
- OFS $9.80
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- OFS 30.67
- LUCD 43.56
- Support Level
- OFS $7.53
- LUCD $1.00
- Resistance Level
- OFS $7.81
- LUCD $1.06
- Average True Range (ATR)
- OFS 0.22
- LUCD 0.04
- MACD
- OFS -0.07
- LUCD -0.00
- Stochastic Oscillator
- OFS 10.27
- LUCD 28.57
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.